VeraCyte Obtains $28,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    Undisclosed South San Francisco, CA 94080
  • Company Description
    Operates as an early stage cancer diagnostics company.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    This investment will be used to bring our advanced testing service in thyroid cancer to market by the end of this year.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    TPG Biotechnology Partners

Trending on Xconomy